"Founded by Italian research scientist Jonathan Fior, Innovative Bioresearch Ltd. is a Web3 biotech company bringing disruptive innovation to pharma, using blockchain technology to decentralize biomedical research and gaming"
About the company founder
Jonathan Fior
Owner and CEO
Jonathan Fior was born in Los Angeles, USA, in 1982 to Italian parents. After moving to Italy as a child, he pursued his education there, graduating with a bachelor's degree in medical biotechnology from the University of Milan—a country renowned for its academic excellence. Passionate about both medical science and computer science, he also gained hands-on experience as a software developer, building apps and games.
After graduation, Jonathan dove into HIV research with a mission to innovate in the field. He conceived the use of irradiated SupT1 cells as decoy targets to prevent CD4+ T cell depletion and reduce HIV cytotoxicity. He first validated this concept in vitro studies, proposing SupT1 cell infusion as a potential cell-based therapy for HIV. To advance it to in vivo testing, he founded Innovative Bioresearch in 2014. He then led a pioneering pilot study of SupT1 cell infusion in humanized mice [1].
Recognizing blockchain's potential to transform pharma, Jonathan became a trailblazer in decentralized science (DeSci) by issuing INNBC (InnovativeBioresearchCoin) in 2018—widely regarded as the original DeSci token. He also authored a highly regarded comprehensive review on salamander regeneration, its differences from human healing, and its promise as a model for novel regenerative and anticancer therapies [2].
Most recently, he published the first peer-reviewed DeSci study [3] (on the Springer-Nature network) demonstrating the real-world application of the INNBC DApp for secure, permanent blockchain-based biomedical data storage and sharing—a work cited by Harvard University.
Building on his software development background, Innovative Bioresearch is now expanding into game development through INNBC Gaming. This includes titles like INNBC Starfighter (a high-res, 60+ FPS bullet-hell shooter evoking 90s arcade classics), available on Steam—further blending blockchain, innovation, and entertainment.
HOW WE OPERATE
For biomedical research projects, Jonathan Fior works as PI (principal investigator), conceiving the experiments and writing the experiment protocol. The work is then assigned to a Contract Research Organization (CRO), which physically performs the experiments. Jonathan Fior then supervises all aspects related to the research, communicating closely with the CRO. Once the experiments are completed, he analyzes the results and writes a scientific paper, which is published in a peer-reviewed scientific journal. This means that although our team is not large, we actually have companies with 100+ people working for us. For example, for our HIV study in humanized mice, we used a state-of-the-art CRO company such as AXENIS, a spin-off of the Institut Pasteur (Paris, France), which has now been acquired by Genoway. This way, we can keep a small, yet strong and great, team. We only publish in open-access scientific journals because we believe in free information and don’t want our data to be hidden behind a paywall. For software projects, they are developed internally.